A detailed history of Fairscale Capital, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Fairscale Capital, LLC holds 537 shares of LLY stock, worth $405,435. This represents 0.42% of its overall portfolio holdings.

Number of Shares
537
Previous 547 1.83%
Holding current value
$405,435
Previous $515 Million 7.63%
% of portfolio
0.42%
Previous 0.46%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$772.14 - $960.02 $7,721 - $9,600
-10 Reduced 1.83%
537 $476 Million
Q2 2024

Aug 13, 2024

BUY
$724.87 - $909.04 $396,503 - $497,244
547 New
547 $515 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $717B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Fairscale Capital, LLC Portfolio

Follow Fairscale Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fairscale Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fairscale Capital, LLC with notifications on news.